Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Tubiana

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Antiviral Therapy|March 31, 2011
Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir disoproxil fumarate treated HIV-HBV-coinfected patientsVincent Thibault, Hind Stitou, Nathalie Desire, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2022
Brief Report: T-Cell Receptor α Repertoire Diversity at Birth After in utero Exposure to HIV Integrase Strand-Transfer InhibitorsJean Pierre de Villartay, Emmanuelle Pannier, Jeanne Sibiude, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 22, 2012
Lateral rectus muscle paralysis induced by ribavirin and pegylated interferon-α2a in a patient with HIV/HCV co-infectionGuillaume Mellon, Hind Stitou, Olivier Aoun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 1, 2019
Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal CohortJeanne Sibiude, Josiane Warszawski, Roland Tubiana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2002
Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitisValérie Zeller, Chantal Truffot, Rachid Agher, et al.
The Pediatric Infectious Disease Journal|February 9, 2022
Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource SettingCatherine Dollfus, Jérome Le Chenadec, Laurent Mandelbrot, et al.
AIDS (London, England)|September 15, 2004
MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II studyChristine Katlama, Jade Ghosn, Roland Tubiana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 30, 2017
HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy OutcomesValérie Benhammou, Roland Tubiana, Sophie Matheron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recoveryJade Ghosn, Luc Paris, Daniel Ajzenberg, et al.
Environmental and Molecular Mutagenesis|December 6, 2017
Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experienceMira Hleyhel, Stéphanie Goujon, Jeanne Sibiude, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Antiviral Therapy|March 31, 2011
Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir disoproxil fumarate treated HIV-HBV-coinfected patientsVincent Thibault, Hind Stitou, Nathalie Desire, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2022
Brief Report: T-Cell Receptor α Repertoire Diversity at Birth After in utero Exposure to HIV Integrase Strand-Transfer InhibitorsJean Pierre de Villartay, Emmanuelle Pannier, Jeanne Sibiude, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 22, 2012
Lateral rectus muscle paralysis induced by ribavirin and pegylated interferon-α2a in a patient with HIV/HCV co-infectionGuillaume Mellon, Hind Stitou, Olivier Aoun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 1, 2019
Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal CohortJeanne Sibiude, Josiane Warszawski, Roland Tubiana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2002
Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitisValérie Zeller, Chantal Truffot, Rachid Agher, et al.
The Pediatric Infectious Disease Journal|February 9, 2022
Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource SettingCatherine Dollfus, Jérome Le Chenadec, Laurent Mandelbrot, et al.
AIDS (London, England)|September 15, 2004
MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II studyChristine Katlama, Jade Ghosn, Roland Tubiana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 30, 2017
HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy OutcomesValérie Benhammou, Roland Tubiana, Sophie Matheron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recoveryJade Ghosn, Luc Paris, Daniel Ajzenberg, et al.
Environmental and Molecular Mutagenesis|December 6, 2017
Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experienceMira Hleyhel, Stéphanie Goujon, Jeanne Sibiude, et al.
Pageof 12